About Watson Pharmaceuticals
Contact Information
FAQ
Prescribing Information
Press Releases
About OAB and Gelnique
®
Home
Press Releases
New Data Suggest That Gelnique
®
Does Not Impact Cognition
Among Healthy Older Adults
September 29, 2009
Watson Launches Gelnique
®
,
First and Only Topical Gel for OAB
May 21, 2009
New Data Presented at AUA’s Annual Conference Prove Gelnique
®
Is an Effective, Safe Option for Female OAB Patients
April 27, 2009
New, Published Gelnique
®
Data Show Efficacy,
Convenience and Excellent Tolerability
March 16, 2009
Watson’s Gelnique
®
Approved by FDA
for the Treatment of OAB
January 27, 2009
Watson Announces Positive Data for Gelnique
®
at SUNA’s Annual Conference
October 8, 2008
